NCT04666220View on ClinicalTrials.gov

VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma

UnknownOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

January 2, 2021

Primary Completion Date

February 28, 2021

Study Completion Date

May 31, 2021

Conditions
Renal Cell CarcinomaAdrenal Carcinoma
Interventions
OTHER

VETC evaluation

We will evaluate VETC presence on tissue specimens

Trial Locations (1)

20089

RECRUITING

Humanitas Clinical and Research Hospital, Rozzano

Sponsors
All Listed Sponsors
lead

Humanitas Clinical and Research Center

OTHER